Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Activation Cyclization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109516946B reveals a novel one-step carbazole synthesis using anthranilic acids, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel C-H activation synthesis of high-B-ring berberine derivatives offers potent IDO1/TDO inhibition for oncology drug development.
Patent CN109438264A reveals high-yield Rh-catalyzed synthesis for indene amines. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Novel copper-catalyzed method for 8-acylquinoline derivatives from benzisoxazoles. Offers green conditions, wide substrate scope, and cost-effective API intermediate manufacturing.
Patent CN111302986B reveals a one-step Rh-catalyzed route for naphthol-based sulfones. Discover cost-effective manufacturing and scalable supply chain solutions for complex pharmaceutical intermediates.
Patent CN109369504B details a novel Pd-catalyzed method for sulfur-containing 3-methyleneisoindolin-1-one derivatives, offering streamlined synthesis for reliable pharmaceutical intermediate suppliers.
Novel efficient route for Xiawu Base B via C-H activation. Reduces cost and improves scalability for pharmaceutical manufacturing using accessible raw materials.
Patent CN113135852B details a metal-free route to 4-aminoquinoline intermediates. Achieve cost reduction in pharma manufacturing with mild conditions and high purity.
Patent CN117720467A reveals a novel 4-step route for chiral catalysts, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN109251192A details Ir-catalyzed synthesis of trifluoromethyl isocoumarins. Offers high purity, mild conditions, and scalable supply chain solutions for pharmaceutical intermediates.
This report analyzes patent CN107382856A for isoquinoline synthesis. It offers mild conditions and high yields. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Patent CN113735756A details a novel Rh-catalyzed C-H activation method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Efficient Mn-catalyzed cyclization method for complex heterocycles. High yield, green chemistry, scalable production for pharma intermediates.
Patent CN110194760B reveals a one-pot Pd-catalyzed route for isoindolinone intermediates, offering high yields and simplified supply chains for API manufacturing.
Patent CN111285846B details a novel Rh-catalyzed C-H activation route for 2-(2-indolyl)-acetates, offering cost reduction and scalable manufacturing for pharma intermediates.
Novel Ru-catalyzed one-step synthesis of spiro-imidazoles via C=N activation. High yield, scalable process for reliable pharmaceutical intermediate supplier.
Novel Pd-catalyzed route for C-3 benzyl indolizines offers simplified operations and high substrate tolerance, ensuring reliable supply for anticancer drug development.
Patent CN112538045A reveals a mild copper-catalyzed route to quinolines, offering cost reduction in API manufacturing and scalable green chemistry solutions.
Patent CN110357879B details a robust Pd-catalyzed route for C-3 benzyl indolizines, offering superior yield and scalability for reliable pharmaceutical intermediate suppliers.
Discover a 95%+ yield, explosion-free synthesis of 2-trifluoromethyl dihydrobenzochromene. Eliminate heavy metal risks and scale to 100MT/yr with our CDMO expertise.